Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Liver Recurrence After Partial Hepatectomy for Intrahepatic Cholangiocarcinoma Using Adjuvant Hepatic Arterial Infusion Pump Chemotherapy - PUMP IV Trial

NCT06888063 is registered in ClinicalTrials.gov with Erasmus Medical Center as lead sponsor.

NCT NCT06888063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06888063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Liver Recurrence After Partial Hepatectomy for Intrahepatic Cholangiocarcinoma Using Adjuvant Hepatic Arterial Infusion Pump Chemotherapy - PUMP IV Trial
Lead sponsor
Erasmus Medical Center
Phase
Phase 2
Overall status
Recruiting
Start date
November 20, 2024
Completion date
September 30, 2033
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intrahepatic bile duct cancer, intrahepatic bile duct carcinoma, intrahepatic cholangiocarcinoma, intrahepatic cholangiocarcinoma (icc)